<DOC>
	<DOC>NCT02641288</DOC>
	<brief_summary>A prospective randomized clinical trial of all the patients undergoing laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass (LRYGB) will be performed. Patients will be randomized in 2 groups: those patients undergoing intraperitoneal ropivacaine irrigation (Experimental Group - EG) and those undergoing intraperitoneal irrigation with normal saline (Control Group - CG).</brief_summary>
	<brief_title>Intraperitoneal Ropivacaine Irrigation in Bariatric Surgery</brief_title>
	<detailed_description>A prospective randomized clinical trial of all the patients undergoing laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass (LRYGB) will be performed. Patients will be randomized in 2 groups: those patients undergoing intraperitoneal ropivacaine irrigation 300mg in 200 ml(Experimental Group - EG) and those undergoing intraperitoneal irrigation with normal saline 200ml (Control Group - CG).</detailed_description>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>Body mass index (BMI) &gt;40 Kg/m2 BMI &gt; 35 Kg/m2 with the presence of comorbidities associated to obesity. patients undergoing other bariatric techniques or revisional surgery allergy to local anesthetics severe underlying cardiovascular diseases chronic renal failure hepatic dysfunction previous foregut surgery patients with any contraindication for bariatric surgery.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>